Greenwich LifeSciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | — | $908.6K | $4.1M |
| FY2025 | — | $353.2K | $6.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | — | $908.6K | $4.1M |
| FY2025 | — | $353.2K | $6.2M |